Publications Database

Eissa N. et al.

Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder.

Frontiers in Neuroscience

Read Full (New Window)

Ellison-Wright Z. , Boardman C. (2015)

Diagnosis and management of ASD in children and adolescents.

Progress in Neurology and Psychiatry

November, 19(6), pp. 28-32.

Read Abstract (New Window) Read Full (New Window)

Faras H. , Ateeqi N. A. , Tidmarsh L. (2010)

Autism spectrum disorders.

Annals of Saudi Medicine

30(4), pp. 295-300

Read Abstract (New Window) Read Full (New Window)

Fischbach R. L. et al. (2016)

Is there concordance in attitudes and beliefs between parents and scientists about autism spectrum disorder?

Autism

April, 20(3), pp. 353-363.

Read Abstract (New Window)

Fitzpatrick M. (2009)

Defeating autism: a damaging delusion.

London: Routledge

Fleming B. (2013)

Research report No. 6: Self-injury in individuals with autism and learning disabilities.

London: Research Autism

Read Full (New Window)

Freitag C. M. (2008)

Genetics of autism.

Journal of Intellectual Disability Research

52(10), pp. 817

Read Abstract (New Window)

Geier D. A. et al. (2008)

Biomarkers of environmental toxicity and susceptibility in autism.

Journal of the Neurological Sciences

280(1), pp. 101-108

Read Abstract (New Window)

Gerlai R. , Gerlai J. (2004)

Autism: a target of pharmacotherapies?

Drug Discov Today

9(8), pp. 366-374

Read Abstract (New Window)

Ghanizadeh A. (2010)

Targeting neurotensin as a potential novel approach for the treatment of autism.

Journal of Neuroinflammation

(7), pp. 58

Read Abstract (New Window) Read Full (New Window)

Ghaziuddin M. , Ghaziuddin N. , Greden J. (2002)

Depression in persons with autism: Implications for research and clinical care.

Journal of Autism and Developmental Disorders

August, 32(4), pp. 299-306.

Read Abstract (New Window)

Goldani A. A. et al. (2014)

Biomarkers in autism.

Frontiers in Psychiatry

Read Abstract (New Window) Read Full (New Window)

Gona J. K. et al. (2015)

Parents' and professionals' perceptions on causes and treatment options for autism spectrum disorders (ASD) in a multicultural context on the Kenyan coast.

PLoS ONE

10(8), e0132729.

Read Abstract (New Window) Read Full (New Window)

Green L. et al. (2001)

Oxytocin and autistic disorder: Alterations in peptide forms.

Biological Psychiatry

50 pp. 609-613.

Read Abstract (New Window)

Griffith G. M. , Hutchinson L. , Hastings R. P. (2013)

I'm not a patient, I'm a person: The experiences of individuals with intellectual disabilities and challenging behavior: A thematic synthesis of qualitative studies.

Clinical Psychology: Science and Practice

20(4), pp. 469-488.

Read Abstract (New Window)

Hampson D. R. , Adusei D. C. , Pacey L. K. K. (2011)

The neurochemical basis for the treatment of autism spectrum disorders and Fragile X syndrome.

Biochemical Pharmacology

81(9), pp. 1078-1086

Read Abstract (New Window)

Happé F. , Ronald A. (2008)

The 'Fractionable Autism Triad': A review of evidence from behavioural, genetic, cognitive and neural research.

Neuropsychology Review

18(4), pp. 287-304

Read Abstract (New Window)

Hay D. (2008)

Fragile X: A challenge to models of the mind and to best clinical practice.

Cortex

44(6), pp. 626-627

Read Abstract (New Window)

Hazen E. P. et al. (2014)

Sensory symptoms in autism spectrum disorders.

Harvard Review of Psychiatry

22(2), pp. 112-24.

Read Abstract (New Window)

National Institute of Mental Health (2006)

Autism Spectrum Disorders (Pervasive Developmental Disorders).

Bethesda, MD: National Institute of Mental Health

Read Full (New Window)